Obesity is a chronic condition, and patients may benefit from taking GLP-1s long term, especially if they also have conditions such as diabetes, cardiovascular disease, obstructive sleep apnea, or metabolic dysfunction-associated steatohepatitis (MASH)
Serious adverse events from GLP-1 therapy are rare in medically supervised settings
[46], a physician who saw his son develop regressive ASD following a vaccination [47]
Ready to boost your energy and improve your wellness
In previous years, he used to share his running achievements on social media, which attracted messages from industry leaders who wanted to join him for a run
We hypothesised that genes highly affected by RYGB could be novel regulators of GLP-1 secretion and production